Healthcare Social Media and Updates

Rare Measles Complication Kills Child Years After Infection
SocialApr 21, 2026

Rare Measles Complication Kills Child Years After Infection

Subacute sclerosing panencephalitis is a rare but fatal side effect of #measles infection, which manifests years after a kid recovers. This story of a family who lost a 10-year old to it is heartbreaking. Renae was too young to be...

By Helen Branswell
Regulatory Hurdles, Not Tech, Slow Biotech Breakthroughs
SocialApr 21, 2026

Regulatory Hurdles, Not Tech, Slow Biotech Breakthroughs

"We need 6 'AlphaFold' moments to compress the drug delivery timeline from 10yrs to a few months" -Demis Yes and the FDA will still take 10yrs to approve it. Safetyism has throttled biotech unnecessarily and the only way to accelerate is to...

By Ryan Bethencourt
Inflammation, Not Cholesterol, Fuels Heart Disease
SocialApr 21, 2026

Inflammation, Not Cholesterol, Fuels Heart Disease

As a medical school professor, I have been saying this for years. Now Scientific American put it on the cover. "Your Heart In Flames" -- May 2026 issue. The argument: chronic inflammation, not cholesterol alone, is the real driver of cardiovascular disease. Up...

By Robert Lufkin, MD
Self‑Experiment Shows High‑Dose Statins May Reduce Exercise Performance
SocialApr 21, 2026

Self‑Experiment Shows High‑Dose Statins May Reduce Exercise Performance

1/2) Given emerging literature I decided to test, in a randomized, placebo-controlled crossover experiment conducted on myself whether high-dose statins would impair my exercise performance.

By Nick Norwitz MD PhD
Nicotinamide Riboside Blocks Lasting Mitochondrial Damage Post‑asphyxia
SocialApr 21, 2026

Nicotinamide Riboside Blocks Lasting Mitochondrial Damage Post‑asphyxia

Long-term region-specific mitochondrial respiration impairment after perinatal asphyxia is prevented by the NAD⁺ donor nicotinamide riboside: A real-time organotypic metabolic profiling approach https://t.co/ZGyAxcnNAC https://t.co/w0VJkAmlHT

By David Barzilai, MD PhD
Patients Seek Google First, Doctors Become Last Resort
SocialApr 21, 2026

Patients Seek Google First, Doctors Become Last Resort

A mother once came to me with her 8 year old. First thing she said wasn't the symptoms. It was "Doctor, I read online that it could be... She had already diagnosed her child. Already half-decided the treatment. She just needed me...

By Vishal Sengar, MD
MyChart’s 250 Deep Links Reveal Limits of Data‑Only Portals
SocialApr 21, 2026

MyChart’s 250 Deep Links Reveal Limits of Data‑Only Portals

Everyone has strong opinions about MyChart. I decided to stop speculating and take a look under the hood. The MyChart APK declares roughly 250 deep links covering everything from geofenced appointment check-in to payer-to-payer data exchange to bedside tablet pairing. The...

By Brendan Keeler
UnitedHealth's Profit Strategy: Deny Patients Needed Medication
SocialApr 21, 2026

UnitedHealth's Profit Strategy: Deny Patients Needed Medication

UnitedHealth just told Wall Street their plan for more profits is to deny more medicine to people. https://t.co/JYysdCAPBw

By Matt Stoller
Tortugas Neuroscience Launches to Develop Brain Disorder Drugs
SocialApr 21, 2026

Tortugas Neuroscience Launches to Develop Brain Disorder Drugs

Tortugas Neuroscience launches with hopes to develop drugs for brain disorders, other conditions https://t.co/zoM69VEQtV via @ADeAngelis_bio

By Adam Feuerstein
Trump Order Boosts Psychedelic Biotech Stocks
SocialApr 21, 2026

Trump Order Boosts Psychedelic Biotech Stocks

Trump executive order lifts psychedelics biotechs https://t.co/3H00cxuF4A by @realJacobBell $GHRS $HRELP $DFTX $ENVB $COMP $ATAI #biotech

By Ben Fidler
Metabolic Health Drives Knee Osteoarthritis Progression
SocialApr 21, 2026

Metabolic Health Drives Knee Osteoarthritis Progression

Knee Osteoarthritis Thread 4: Metabolic Health and the Knee. Your metabolic health will directly impact how your knee feels more than you can imagine. Your metabolic health directly influences how quickly your arthritis progresses and how your cartilage responds to...

By Howard Luks, MD
Serif Targets Revolutionary Genetic Medicine Platform
SocialApr 21, 2026

Serif Targets Revolutionary Genetic Medicine Platform

Serif, Flagship’s latest biotech, aims to make a new kind of genetic medicine https://t.co/kvmbF3xYKu by @gwendolynawu #biotech #startups @FlagshipPioneer

By Ben Fidler
Endless ER Wait Leaves Mom Still Unattended
SocialApr 21, 2026

Endless ER Wait Leaves Mom Still Unattended

Spent the whole evening in the ER waiting room and we’re still waiting so that my mom gets medical attention 🫠

By The Space Mechanic
Celastrol Disrupts Hsc70‑Bim to Boost Longevity, Reduce Fibrosis
SocialApr 21, 2026

Celastrol Disrupts Hsc70‑Bim to Boost Longevity, Reduce Fibrosis

Celastrol Targets Hsc70-Bim Interaction as a Novel Senolytic to Extend Lifespan and Mitigate Organ Fibrosis https://t.co/Iv51QlhH5l

By David Barzilai, MD PhD
Cerebral Palsy Doctor Explains Real Impact of Policy Cuts
SocialApr 21, 2026

Cerebral Palsy Doctor Explains Real Impact of Policy Cuts

I have cerebral palsy and I’m a doctor. Here’s what policy cuts mean for patients like me. [PODCAST] http://dlvr.it/TS7zmV Podcast #PublicHealthPolicy

By Kevin Pho, MD (KevinMD)
Group Coaching Boosts Mental Health in Seniors
SocialApr 21, 2026

Group Coaching Boosts Mental Health in Seniors

Community as Medicine: A Qualitative Study of How Group Health Coaching and Social Connection Improve Mental Well-Being in Older Adults https://t.co/U8mo1sYgt1 @MDPIOpenAccess https://t.co/2HCt6wBBSm

By David Barzilai, MD PhD
Resistance Training Cuts Fat and Boosts Grip Strength
SocialApr 21, 2026

Resistance Training Cuts Fat and Boosts Grip Strength

Exercise, nutrition, physical agent therapy in older adults with sarcopenic obesity: a systematic review and network meta-analysis RT can reduce BF% while simultaneously improving grip strength, representing an effective management strategy for sarcopenic obesity. https://t.co/p0wR2R5M1E

By David Barzilai, MD PhD
Four Overlooked AACR Early-Stage Agents Worth Watching
SocialApr 21, 2026

Four Overlooked AACR Early-Stage Agents Worth Watching

While everyone was watching KRAS, some of AACR’s promising early stage pipeline agents were easy to miss. Here's an analysis on four examples which caught my eye and are well worth watching to see how they develop in the...

By Sally Church
ER Doctors Question Band‑Aid Role Amid Systemic Failure
SocialApr 21, 2026

ER Doctors Question Band‑Aid Role Amid Systemic Failure

An ER physician with 35 years of experience said it out loud: "Have I been part of the problem rather than part of the solution? Have I just been a band-aid?" That is Kenneth Ro, and it is the quiet...

By Kevin Pho, MD
Irregular Bedtimes Double Risk of Major Cardiac Events
SocialApr 21, 2026

Irregular Bedtimes Double Risk of Major Cardiac Events

Sleep timing irregularity in midlife: association with incident major adverse cardiac events and cardiovascular disease mortality over a 10-year follow-up 🫀Individuals with irregular bedtimes had a 2-fold higher risk of MACEs compared to those with regular bedtimes Irregular sleep midpoints? Also a...

By David Barzilai, MD PhD
Patients Now Save Money Using Weight‑Loss Injections
SocialApr 21, 2026

Patients Now Save Money Using Weight‑Loss Injections

So I saw a Threads post yesterday and it was an interesting topic. I've spoken to my Aussie patients about this too. Dulu ingat weight loss injection = mahal. But ramai patients during consults now cakap benda sama: “Dr Dinar, I've actually been...

By Marissa Dinar, MD
Tenofovir Alafenamide Cuts Biological Age in Adults
SocialApr 21, 2026

Tenofovir Alafenamide Cuts Biological Age in Adults

An FDA-Approved Tenofovir Alafenamide-Based Antiretroviral Therapy Reduces Biological Age in Healthy Adults: First Human Proof-of-Concept for Retrotransposon-Targeted Gerotherapeutics 💫 https://t.co/FFvTmJv2zv https://t.co/DHHQ18nAmy

By David Barzilai, MD PhD
HDAC7 Loss Predicts Poor DLBCL Outcomes; Restoration Stops Tumor
SocialApr 20, 2026

HDAC7 Loss Predicts Poor DLBCL Outcomes; Restoration Stops Tumor

Loss of the HDAC7 protein in diffuse large B cell lymphoma is linked to poorer outcomes, while restoring HDAC7 in cancer cells halts tumor growth, highlighting its potential as both a biomarker and therapeutic target. bloodcancer

By Phys.org Threads
Gene Therapy Works Best for Deaf Children Aged 5‑8
SocialApr 20, 2026

Gene Therapy Works Best for Deaf Children Aged 5‑8

AAV gene therapy for autosomal recessive deafness 9: a single-arm trial 🌟“Gene therapy for congenital deafness has shown promising results in children but lacks data in older populations… . An age-dependent therapeutic effect was observed, with optimal outcomes in 5- to...

By David Barzilai, MD PhD
Getting a Tetanus Shot Before Unexpected Nail Mishaps
SocialApr 20, 2026

Getting a Tetanus Shot Before Unexpected Nail Mishaps

called a general appt line to get a tetanus shot operator: is there a specific time that you need this done by? me: i mean, i guess before i step on a rusty nail, i mean, im not looking to self harm...

By Andrea Carr
China Debuts Pharmacy Robot Processing 370 Orders Daily
SocialApr 20, 2026

China Debuts Pharmacy Robot Processing 370 Orders Daily

China Launches First Pharmacy #Robot Handling 370 Orders a Day by @CGTNOfficial #MedTech #HealthTech #Tech #Healthcare https://t.co/DjZ0teE6fF

By Ron van Loon
Vaccinated Donor Plasma Contains No Spike Proteins or mRNA
SocialApr 20, 2026

Vaccinated Donor Plasma Contains No Spike Proteins or mRNA

One of the top questions I get about young plasma exchange (YPE): “What if the donor was vaccinated? Does that mean I’m getting spike proteins or mRNA injected into me?” Short answer: No. Here’s the breakdown... https://t.co/JDoAi2yPmR

By Ben Greenfield
Anktiva Needs Trial Data Before FDA Approval
SocialApr 20, 2026

Anktiva Needs Trial Data Before FDA Approval

For the umpteenth time, these posters have zero relevance to Anktiva unless, or until, $IBRX conducts/completes randomized clinical trials that demonstrate the drug improves outcomes for cancer patients w/ lymphopenia. @LoriMills4CA42 and the rest of you can idolize @DrPatrick ...

By Adam Feuerstein
GLP‑1 Drugs Aren’t a One‑size‑fit Solution
SocialApr 20, 2026

GLP‑1 Drugs Aren’t a One‑size‑fit Solution

Should everyone be taking a GLP-1 medication? From my discussion with @RealDoctorMike on his podcast https://t.co/d3M8cFHggz

By Biolayne (Layne Norton, PhD)
Higher Muscle Strength Cuts Mortality Risk in Elderly Women
SocialApr 20, 2026

Higher Muscle Strength Cuts Mortality Risk in Elderly Women

Muscular Strength and Mortality in Women Aged 63 to 99 Years 👉 “this study of ambulatory older women, greater muscular strength was associated with lower mortality even when controlling for accelerometer-measured PA and sedentary time, walking speed, and systemic inflammation.” https://t.co/xi913FibKy

By David Barzilai, MD PhD
AI's First Use Turns Skeptical Radiologists Into Advocates
SocialApr 20, 2026

AI's First Use Turns Skeptical Radiologists Into Advocates

In healthcare, you only understand how game-changing AI is once you use it. What strikes me most is how reliably opinions flip. The skeptic radiologist goes from “I don’t need this” to “I can’t imagine working without it.” Not occasionally. Almost every time.

By Amine Korchi, MD
GLP‑1s Preserve Muscle Better Than Diet‑Only Weight Loss
SocialApr 20, 2026

GLP‑1s Preserve Muscle Better Than Diet‑Only Weight Loss

Summary for patients on GLP-1 drugs and non-drug weight loss re: muscle mass impact @AnnalsofIM https://t.co/pSDhbKkXwb https://t.co/qM7OgVJwQg

By Eric Topol
Garlic-Derived DAS Outperforms Metformin, Extending Mouse Lifespan
SocialApr 20, 2026

Garlic-Derived DAS Outperforms Metformin, Extending Mouse Lifespan

👉 “Chronic treatment with DAS (found in garlic 🧄) freshly added to the diet weekly revealed geroprotective effects, since it extended lifespan and improved metabolic homeostasis, locomotor function, and relevant cognitive parameters in wild-type male mice fed with an STD....

By David Barzilai, MD PhD
NIH Grant Funding Slashes, Women’s Health Projects Plummet
SocialApr 20, 2026

NIH Grant Funding Slashes, Women’s Health Projects Plummet

Elections have consequences.... The number of competitive grants awarded by the NIH is down by more than half compared with the same period last year. Overall, the NIH supported over 2,700 fewer scientific projects in fiscal 2025, about a 15%...

By Daniel Kraft, MD
Measles Outbreak Could Cost $7 B, Anti‑Vax Shift
SocialApr 20, 2026

Measles Outbreak Could Cost $7 B, Anti‑Vax Shift

Two Bloomberg measles stories - $7 billion in potential costs and some anti-vaxers coming to their senses: https://t.co/oLkHtaLjmY https://t.co/qXAG8FfXIx

By Peter Suzman
CRISPR Advances Outpace Ethics in Germline Editing Debate
SocialApr 20, 2026

CRISPR Advances Outpace Ethics in Germline Editing Debate

In 2018, He Jiankui edited the genomes of two human embryos, brought them to term, and went to prison for it. The babies are now children. We don't know how they're doing. Seven years later, base editing and prime editing can...

By John Cumbers
Free Virtual Summit on Multiomics & NGS – Register Now
SocialApr 20, 2026

Free Virtual Summit on Multiomics & NGS – Register Now

Join @julemieux1 and as we co-host THE STATE OF MULTIOMICS & NGS @Genbio virtual summit next Wednesday, April 29th: Sponsored by @illumina - registration is free. https://t.co/NJErGGe5qb https://t.co/dJuRqy8Np7

By Kevin Davies
Blood and Fat Markers Forecast Heart Disease Risk
SocialApr 20, 2026

Blood and Fat Markers Forecast Heart Disease Risk

Neutrophil-to-Lymphocyte Ratio, Bone Marrow, and Visceral Fat Metabolism as Predictors of Future Cardiovascular Disease in an Asymptomatic Healthy Population https://t.co/Oq1a3fH5qa

By Michael Lustgarten, PhD
Combine Meds and Lifestyle for Equitable Hypertension Control
SocialApr 20, 2026

Combine Meds and Lifestyle for Equitable Hypertension Control

Healthy Lifestyle After Hypertension—A Call to Action 💡Integrate antihypertensive medication use and lifestyle modification to deliver more effective and equitable population-level hypertension management and cardiometabolic disease prevention. https://t.co/wENgycQ8hz

By David Barzilai, MD PhD
LLY's Second in Vivo CAR‑T Deal via Kelonia Buyout
SocialApr 20, 2026

LLY's Second in Vivo CAR‑T Deal via Kelonia Buyout

Kelonia turns #ASH25 late-breaker into buyout, with $LLY's second move into in vivo Car-T. Via @ApexOnco -> https://t.co/NPhdnuhPu3 $AZN $GILD

By Jacob Plieth
Oracle Health Joins CMSGov Aligned Networks to Boost Data Access
SocialApr 20, 2026

Oracle Health Joins CMSGov Aligned Networks to Boost Data Access

For decades, the @OracleHealth team has been committed to making sure patients have access to and remain in control of their health data. Our participation in the @CMSGov Aligned Networks underscores this commitment, and will help improve how clinicians and...

By Seema Verma
Key Overlooked Factors in Clinical Trial Design
SocialApr 20, 2026

Key Overlooked Factors in Clinical Trial Design

New presentation on things we often forget to consider when designing a clinical trial: https://t.co/BVlSCIHdLu #Statistics #clinicaltrials

By Frank Harrell
Deadliest Cancers Receive the Least Federal Funding
SocialApr 20, 2026

Deadliest Cancers Receive the Least Federal Funding

The worst cancers with respect to lethality get the least federal funding support https://t.co/uCJXYgpB3c https://t.co/woqbMo1oYp

By Eric Topol
Inside the $3.25B Eli Lilly Acquisition: Memo and Deck
SocialApr 20, 2026

Inside the $3.25B Eli Lilly Acquisition: Memo and Deck

Read the memo and slide deck that led to th creation of the company Eli Lilly bought for $3.25 billion today https://t.co/cNoTs7M4YM

By Matthew Herper
Nektar Jumps as Alopecia Drug Shows Promise
SocialApr 20, 2026

Nektar Jumps as Alopecia Drug Shows Promise

Nektar surges again as alopecia drug shows new promise in extension study https://t.co/UV0ccY4HiR @ByJonGardner $NKTR + 25% $LLY

By Ben Fidler
First Gut Microbiome Signature Predicts Parkinson’s Risk in Healthy Carriers
SocialApr 20, 2026

First Gut Microbiome Signature Predicts Parkinson’s Risk in Healthy Carriers

We've known the gut-brain axis is a key underpinning of Parkinson's disease. Today, for the 1st time, a gut microbiome signature denoting risk found in healthy individuals with genetic predisposition @NatureMedicine https://t.co/oDTItnis5L

By Eric Topol
2018 Study Predicts Psilocybin Should Move to Schedule 4
SocialApr 20, 2026

2018 Study Predicts Psilocybin Should Move to Schedule 4

The psychedelic executive order requires government to "initiate and complete review of any product containing a Schedule I substance that has successfully completed Phase 3 clinical trials ... so that rescheduling ... may proceed as quickly as practicable". My 2018...

By Matthew W. Johnson
AACR 2026 Unveils Merck Breakthrough and Lung Cancer Hope
SocialApr 20, 2026

AACR 2026 Unveils Merck Breakthrough and Lung Cancer Hope

AACR 2026: Revolution’s next prospect, Merck’s reveal and a lung cancer battle https://t.co/u2iwCd3DKv #AACR26 $RVMD $MRK $NUVL $NUVB

By Ben Fidler
Biotech Must Prioritize Collaboration, Not Nationalism, for Patients
SocialApr 20, 2026

Biotech Must Prioritize Collaboration, Not Nationalism, for Patients

After a week in Washington DC at one of the best new annual events by @semafor , I came to China for just 2 nights to meet some of my friends from Washington. I even had to skip this year's...

By Alex Zhavoronkov, PhD